4D bioprinting of dynamic skin constructs: stimuli-responsive materials for adaptive wound healing

Food Science of Animal Resources · Springer Nature · 2026-11-13 · DOI: 10.1007/s13205-026-05118-x

Аннотация

Wound healing remains a major clinical challenge, particularly for patients with chronic conditions such as diabetes, where impaired tissue repair contributes to significant morbidity and mortality. Conventional static wound dressings and three-dimensional (3D) bioprinted constructs fail to dynamically adapt to the evolving biochemical and biophysical microenvironment of a healing wound. The emergence of four-dimensional (4D) bioprinting, which incorporates time as a programmable dimension, offers a transformative paradigm by enabling printed scaffolds to undergo controlled shape morphing, drug release, and functional adaptation in response to stimuli, including temperature, pH, reactive oxygen species (ROS), light, magnetic fields, and enzymatic activity. This critical narrative review adopts an operational definition of 4D bioprinting and applies it as an inclusion criterion: additive fabrication that places cells or cell-instructive matrix under spatial control, a transformation programmed into that spatial arrangement during printing, and a measurable post-fabrication change with a defined trigger, threshold and rate. Judged against these criteria, much of the literature presented as 4D bioprinting comprises cast responsive hydrogels, electrospun meshes, microneedle arrays and smart dressings, and every system discussed here is accordingly assigned to one of four evidence tiers. We examine the measurement caveats that qualify wound pH, temperature and reactive oxygen species as design targets; the levers that set the magnitude, direction and rate of morphing; the three ASTM-aligned biofabrication families and how each enables or constrains programmed transformation; cell-generated contractile force as an endogenous actuator; and the failure modes peculiar to 4D systems, including threshold drift in protein-rich exudate, actuation slower than the biology it targets, single-shot chemistry and multi-stimulus cross-talk. Autonomous stimulus-responsive therapeutics are distinguished from genuine closed-loop sense-and-treat platforms. Evidence remains overwhelmingly rodent-based, no 4D bioprinted skin construct has entered a registered clinical trial, and almost no study compares an adaptive construct against a compositionally identical static control—the comparison that will decide whether 4D functionality earns its complexity.

Читать у издателя →

Похожие статьи